2 weeks Ago MIRA Pharmaceuticals ( NASDAQ: MIRA ) said on Monday that it has signed a binding letter of intent (LOI) to acquire SKNY Pharmaceuticals. The company said the transaction includes a $5 million capital infusion-comprised of cash or equivalent consideration-into MIRA, reinforcing its financial position and.
